Aaron Markowitz and his wife made the decision to sponsor a Twitterthon because their family has been closely affected by cancer. Both his wife's mother, Janice Sitter and her aunt, Cynthia Ciotti were diagnosed with breast cancer in 2004-05. While their treatments were successful, and they have been cancer free for over 5 years, they realize the fight is never over and it could come back at any time.
Aaron and his wife are dedicating their sponsorship to the Susan G. Komen Foundation in the names of those in the family who have been impacted by breast cancer. We thank Aaron and his wife for sponsoring today's Twitterthon to help raise more awareness in the fight to end cancer.
History of the Twitterthon
We created the Twitterthon to allow people to raise $ and awareness for their favorite cancer charity by tweeting and following. Over the last 15 months we have raised over $43,500 through Twitterthons with 100% going towards the cancer charity. Most of the sponsorships of our Twitterthons have a minimum of a $2,500 donation.
While our goal is to have a "sponsor each day" for our Twitterthons, we realize that a $2,500 donation is a hefty price tag for most people. So for the month of February only, we are providing opportunities for "micro" Twitterthons where the minimum donation is $500. Our goal is a $500 sponsor a day (20 workdays in the month) to accumulate $10,000 once February is over, with ALL proceeds going to cancer charities by TWEETING & FOLLOWING. How easy is that?
We have the following commitments (charities being sponsored) to this point
Feb 1 Susan G. Komen by sponsor @AMarkowitz33
Feb 2 International Mesothelioma Program
Feb 4 ***Surprise Announcement
Feb 8 Leukemia & Lymphoma Society
Feb 18 Dallas Children's Medical Center
Five down, 15 to go. Help us achieve our goal for a "Sponsor A Day in the Month of February". February 3 is the next available. If you are interested in sponsoring, email us at bonham.darah@gmail.com. Help spread our movement......
"Power of the People, To Unite, To @abolishcancer"
No comments:
Post a Comment